Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2016 Jun 2;25(8):1240–1250. doi: 10.1158/1055-9965.EPI-15-1079

Table 4.

Multinomial Logistic Regression Models for Treatment Preference

Model 1-Demographic and clinical variables (n=1136) Model 2 - All Variables (n=1090)#
AS vs AT (ref) No Preference vs AT (ref) Overall p value AS vs AT (ref) No Preference vs AT (ref) Overall p value
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Age
    less than 60 (ref) 1 1 1 1
    60-69 1.49 1.02 - 2.19 1.17 0.82 - 1.68 1.64 1.07 - 2.51 1.34 0.84 - 2.14
    70+ 1.79 0.94 - 3.39 1.05 0.55 - 2 2 0.95 - 4.18 1.02 0.43 - 2.42
Education *
        < High School (ref) 1 1 1 1
        1-3 Years College 1.13 0.7 - 1.84 1.26 0.78 - 2.03 1.37 0.8 - 2.34 1.63 0.85 - 3.15
        4 Year College 1.29 0.77 - 2.17 1.73 1.05 - 2.85 1.61 0.9 - 2.89 2.19 1.1 - 4.36
        > Grad School 1.71 1.02 - 2.87 2.29 1.38 - 3.8 2.05 1.12 - 3.74 2.84 1.42 - 5.69
Race
    Black(ref) 1 1 1 1
    White 1.44 0.83 - 2.51 0.85 0.52 - 1.4 1.28 0.71 - 2.3 0.71 0.38 - 1.33
    Other 2.1 0.92 - 4.79 0.99 0.45 - 2.18 1.59 0.64 - 3.94 0.68 0.24 - 1.91
Elixhauser Index
    0 (ref) 1 1 1 1
    1 0.9 0.58 - 1.4 1.15 0.76 - 1.75 0.87 0.54 - 1.4 1.09 0.64 - 1.86
    2 0.65 0.38 - 1.12 1.13 0.69 - 1.83 0.7 0.39 - 1.27 1.36 0.73 - 2.55
    3+ 1.14 0.71 - 1.82 0.84 0.53 - 1.35 1.19 0.7 - 2.01 0.72 0.38 - 1.35
PSA at diagnosis
    <= 4 (ref) 1 1 1 1
    4.1 to 7.9 1.32 0.74 - 2.37 0.87 0.52 - 1.45 1.14 0.6 - 2.15 0.88 0.44 - 1.76
    8.0 to 10.0 0.79 0.39 - 1.61 0.73 0.38 - 1.38 0.56 0.26 - 1.23 0.75 0.32 - 1.72
Days from Diagnosis to Baseline
(one-unit increase = 1 SD) 1.18 0.99 - 1.4 1.03 0.87 - 1.23 1.19 0.98 - 1.44 0.97 0.77 - 1.21
Number of positive cores 0.73 0.66 - 0.81 0.96 0.9 - 1.03 *** 0.74 0.67 - 0.82 0.95 0.86 - 1.04 ***
First Degree relative with prostate cancer *** **
    No (ref) 1 1 1 1
    Yes 0.61 0.42 - 0.88 0.55 0.38 - 0.78 0.58 0.38 - 0.87 0.56 0.35 - 0.88
Urologist Recommendation *** ***
    No recommendation/Patient Decide (ref)
    AS/WW 20.02 10.36 - 38.7 3.15 1.5 - 6.61 17.89 8.98 - 35.66 2.58 1.09 - 6.08
    AT 0.43 0.29 - 0.66 0.64 0.45 - 0.93 0.41 0.26 - 0.65 0.56 0.34 - 0.92
    no discussion with urologist 4.58 2.17 - 9.69 12.27 6.08 - 24.76 3.38 1.51 - 7.57 5.62 2.41 - 13.11
# of decision making resources used ***
    0/1 (ref) -- -- -- -- 1 1
    2 -- -- -- -- 0.64 0.36 - 1.14 0.81 0.41 - 1.6
    3 -- -- -- -- 0.39 0.21 - 0.71 1.01 0.5 - 2
    4+ -- -- -- -- 0.28 0.15 - 0.52 0.81 0.4 - 1.66
Sure Scale (certainty about treatment preference) ***
    (one-unit increase = 1 SD) -- -- -- -- 0.57 0.41 - 0.8 0.13 0.09 - 0.17
Health Worry Scale (prostate cancer anxiety)
    (one-unit increase = 1 SD) -- -- -- -- 1.22 1.003 - 1.48 1.05 0.84 - 1.31
Degner Control Preference Scale ***
    Decision with Doctor or Independent (ref) -- -- -- -- 1 1
    Shared decision -- -- -- -- 2.34 1.37 - 3.99 3.09 1.73 - 5.52
Knowledge Scale ***
(one-unit increase = 1 SD) -- -- -- -- 1.77 1.43 - 2.18 1.63 1.28 - 2.06
Awareness of Low Risk Level ***
    Incorrect/DK (ref) -- -- -- -- 1 1
    Correct (low risk) 3.97 1.96 - 8.06 1.74 0.87 - 3.48

Notes: AS (active surveillance), AT (active treatment), NP (no preference).

#

Model 2 has fewer subjects than Model 1 due to missing data in the psychological and decisional variables included in Model 2.

*

p value <0.05

**

p value <0.01

***

p value <0.001